SG
TMO icon

StoneX Group’s Thermo Fisher Scientific TMO Stock Holding History

StoneX Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$730K Sell
1,454
-436
-23% -$209K 0.03% 436
2026
Q1 		$930K Sell
1,890
-1,609
-46% -$873K 0.05% 276
2025
Q4 		$2.03M Sell
3,499
-401
-10% -$227K 0.09% 181
2025
Q3 		$1.89M Sell
3,900
-83
-2% -$38.6K 0.08% 199
2025
Q2 		$1.62M Sell
3,983
-21
-0.5% -$8.78K 0.08% 220
2025
Q1 		$1.99M Buy
4,004
+694
+21% +$376K 0.11% 175
2024
Q4 		$1.72M Buy
3,310
+512
+18% +$281K 0.09% 190
2024
Q3 		$1.73M Buy
2,798
+358
+15% +$212K 0.13% 143
2024
Q2 		$1.35M Buy
2,440
+448
+22% +$257K 0.11% 163
2024
Q1 		$1.16M Buy
1,992
+240
+14% +$135K 0.1% 181
2023
Q4 		$930K Buy
1,752
+198
+13% +$95.8K 0.09% 192
2023
Q3 		$787K Buy
1,554
+60
+4% +$32K 0.09% 208
2023
Q2 		$780K Sell
1,494
-70
-4% -$37.8K 0.08% 214
2023
Q1 		$902K Buy
1,564
+234
+18% +$132K 0.1% 190
2022
Q4 		$733K Sell
1,330
-31
-2% -$16.4K 0.09% 211
2022
Q3 		$691K Sell
1,361
-533
-28% -$298K 0.09% 206
2022
Q2 		$1.03M Buy
1,894
+223
+13% +$123K 0.13% 158
2022
Q1 		$987K Buy
1,671
+465
+39% +$267K 0.08% 218
2021
Q4 		$805K Buy
1,206
+185
+18% +$116K 0.09% 207
2021
Q3 		$584K Buy
1,021
+97
+10% +$53.2K 0.08% 230
2021
Q2 		$466K Buy
924
+167
+22% +$78.8K 0.07% 256
2021
Q1 		$346K Buy
757
+26
+4% +$12.4K 0.06% 269
2020
Q4 		$341K Buy
731
+141
+24% +$66.1K 0.08% 249
2020
Q3 		$261K Buy
+590
New +$244K 0.08% 251
2017
Q3 		– Sell
-1,581
Closed -$276K – 337
2017
Q2 		$276K Buy
+1,581
New +$266K 0.09% 299

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

StoneX Group's TMO Position: Q2 2026 in Review

StoneX Group reduced its Thermo Fisher Scientific (TMO) stake by 23% in Q2 2026, selling an estimated $209K and leaving 1,454 shares worth $730K. The position accounts for 0.03% of the portfolio, ranked #436.

StoneX Group first reported a position in TMO in Q2 2017 and has held it in 25 quarters since. The position peaked at $2.03M in Q4 2025. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • StoneX Group held 1,454 shares of Thermo Fisher Scientific worth $730K as of Q2 2026.
  • StoneX Group sold 436 Thermo Fisher Scientific shares in Q2 2026, an estimated $209K.
  • Thermo Fisher Scientific made up 0.03% of StoneX Group's portfolio in Q2 2026, its #436 holding.
  • StoneX Group first reported a position in Thermo Fisher Scientific in Q2 2017 and has held it in 25 quarters since.
  • StoneX Group's Thermo Fisher Scientific position peaked at $2.03M in Q4 2025.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.